Suppr超能文献

癫痫患者的药物代谢:体内与体外的相关性

Drug metabolism in epileptics: in vivo and in vitro correlations.

作者信息

Sotaniemi E A, Pelkonen R O, Ahokas J, Pirttiaho H I, Ahlqvist J

出版信息

Br J Clin Pharmacol. 1978 Jan;5(1):71-6. doi: 10.1111/j.1365-2125.1978.tb01600.x.

Abstract
  1. The effect of inducing drug therapy on the relationship between in vitro (cytochrome P-450 content) and in vivo (antipyrine kinetics) was investigated by comparing eleven consecutively treated epileptics with two groups of controls, eleven subjects with normal liver histology and eleven disease matched non-epileptics, all underwent diagnostice liver biopsy. 2. The epileptics had significantly higher cytochrom P-450 level in biopsies and they also metabolized antipyrine faster than the controls. 3. Decrease in antipyrine half-life in epileptics was related with alterations in liver histology, whereas the level of cytochrome P-450 was not. 4. There was a linear relationship between these two indices of enzyme induction when regressed on logarithmic data.
摘要
  1. 通过比较11例接受连续治疗的癫痫患者与两组对照组(11例肝组织学正常的受试者和11例疾病匹配的非癫痫患者,所有患者均接受了诊断性肝活检),研究了诱导药物治疗对体外(细胞色素P - 450含量)和体内(安替比林动力学)之间关系的影响。2. 癫痫患者活检中的细胞色素P - 450水平显著更高,并且他们代谢安替比林的速度也比对照组更快。3. 癫痫患者安替比林半衰期的缩短与肝组织学改变有关,而细胞色素P - 450水平则无关。4. 当对对数数据进行回归分析时,这两个酶诱导指标之间存在线性关系。

相似文献

1
Drug metabolism in epileptics: in vivo and in vitro correlations.
Br J Clin Pharmacol. 1978 Jan;5(1):71-6. doi: 10.1111/j.1365-2125.1978.tb01600.x.
2
Liver size and indices of drug metabolism in epileptics.
Br J Clin Pharmacol. 1978 Sep;6(3):273-8. doi: 10.1111/j.1365-2125.1978.tb04597.x.
3
Drug metabolism in man: in vivo and in vitro correlations.
Arch Toxicol Suppl. 1978(1):339-42. doi: 10.1007/978-3-642-66896-8_72.
4
Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.
Eur J Clin Pharmacol. 1982;22(5):441-5. doi: 10.1007/BF00542550.
5
Serum zinc and serum copper and indices of drug metabolism in alcoholics.
Eur J Clin Pharmacol. 1977 Oct 14;12(2):147-51. doi: 10.1007/BF00645136.
6
Liver size and indices of drug metabolism in alcoholics.
Eur J Clin Pharmacol. 1978 Mar 17;13(1):61-7. doi: 10.1007/BF00606684.
7
Histological changes in the liver and indices of drug metabolism in alcoholics.
Eur J Clin Pharmacol. 1977 Apr 20;11(4):295-303. doi: 10.1007/BF00607680.
8
Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
Eur J Drug Metab Pharmacokinet. 1982 Oct-Dec;7(4):255-8. doi: 10.1007/BF03189627.
9
Drug metabolism in diabetic subjects with fatty livers.
Br J Clin Pharmacol. 1984 Dec;18(6):895-9. doi: 10.1111/j.1365-2125.1984.tb02561.x.
10
Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage.
Eur J Clin Pharmacol. 1977 Dec 28;12(6):429-35. doi: 10.1007/BF00561062.

引用本文的文献

1
Antiepileptic drugs. A review of clinically significant drug interactions.
Drug Saf. 1993 Sep;9(3):156-84. doi: 10.2165/00002018-199309030-00003.
3
Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.
Br J Clin Pharmacol. 1980 Apr;9(4):399-405. doi: 10.1111/j.1365-2125.1980.tb01068.x.
4
Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro.
Eur J Clin Pharmacol. 1981;20(1):39-46. doi: 10.1007/BF00554665.
6
Pharmacokinetic interactions with antiepileptic drugs.
Clin Pharmacokinet. 1982 Jan-Feb;7(1):57-84. doi: 10.2165/00003088-198207010-00004.
7
Drug interactions with phenytoin.
Drugs. 1981 Feb;21(2):120-37. doi: 10.2165/00003495-198121020-00003.
8
Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.
Br J Clin Pharmacol. 1980 Jan;9(1):11-9. doi: 10.1111/j.1365-2125.1980.tb04790.x.
10
Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine.
Br J Clin Pharmacol. 1983;15 Suppl 2(Suppl 2):205S-211S. doi: 10.1111/j.1365-2125.1983.tb05867.x.

本文引用的文献

1
The fate of antipyrine in man.
J Pharmacol Exp Ther. 1950 Jan;98(1):97-104.
2
Drug interaction with hepatic microsomal cytochrome.
Mol Pharmacol. 1966 Mar;2(2):187-90.
3
The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 hemes in the rat.
Biochim Biophys Acta. 1970 Jan 27;201(1):20-5. doi: 10.1016/0304-4165(70)90005-x.
4
The action of drugs on bilirubin metabolism in man.
Ann N Y Acad Sci. 1971 Jul 6;179:403-10. doi: 10.1111/j.1749-6632.1971.tb46917.x.
5
Effect of diphenylhydantoin on hepatic drug hydroxylation.
Eur J Clin Pharmacol. 1974 Jul 26;7(4):281-5. doi: 10.1007/BF00560345.
7
Drug metabolism and androgen control therapy in prostatic cancer.
Clin Pharmacol Ther. 1973 May-Jun;14(3):413-7. doi: 10.1002/cpt1973143413.
9
Substrate interaction with hydroxylase system in liver microsomes.
Biochem Biophys Res Commun. 1966 Mar 22;22(6):620-6. doi: 10.1016/0006-291x(66)90191-4.
10
Cytochromes P-450 and b5 in human liver microsomes.
Clin Pharmacol Ther. 1969 Sep-Oct;10(5):655-9. doi: 10.1002/cpt1969105655.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验